DUBLIN--(BUSINESS WIRE)--The "Glaucoma Surgery Devices Market Analysis, By Surgery Type By Product type, By End User, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The glaucoma surgery devices market size is estimated to be USD 845.21 million in 2021 and is expected to witness a CAGR of 26.31% during the forecast period 2022-2029.
Companies Mentioned
- Bausch & Lomb Inc. (Valeant Pharmaceuticals International Inc.)
- Glaukos Corporation
- New World Medical Inc.
- Alcon Inc. (Novartis AG)
- Ellex Medical Lasers Ltd
- Johnson & Johnson
- Abbott Medical Optics (Abbott Laboratories)
- Topcon Corporation
- Lumenis Ltd.
- Allergan Plc.
The elderly population is increasing, which increases the risk of eye disease, and the rising prevalence of glaucoma are the factors contributing to the market growth. However, lack of knowledge regarding eye-care is expected to hinder the growth.
By Surgery Type
In terms of surgery type, the market is divided into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. In 2021, the conventional glaucoma surgeries segment accounted for the largest revenue share owing to fact that traditional glaucoma procedures have fewer side effects and are therefore the surgeons' first choice for treating various types of glaucoma
By Product Type
Based on product type, the market is categorized into glaucoma laser devices, implants & stents, and glaucoma drainage devices. In 2021, the glaucoma drainage devices accounted for the highest revenue share due to increase in acceptance of drainage devices like Ahmed valves or aqueous shunts over traditional glaucoma procedures.
By End User
On the basis of end user, the market is categorized into ophthalmic clinic, hospitals, and ambulatory surgical centres. In the global market, the hospitals segment accounted for the largest revenue share in 2021 owing to the fact that hospitals are a more popular option for ophthalmic procedures.
Regional Markets In 2021, North America region accounted for the highest revenue in the glaucoma surgery devices market and is expected to maintain its dominance during the forecast period. This is attributed to the ageing population, an increase in glaucoma cases, the availability of more comprehensive treatments, improved healthcare facilities, and greater public awareness.
For more information about this report visit https://www.researchandmarkets.com/r/m8isso
